Adjuvant Durvalumab Extends Survival in Small Cell Lung Cancer
Significantly longer overall and progression-free survival seen among patients with limited-stage small cell lung cancer
Long-Term Survival Benefit Seen for Nivolumab in Advanced Melanoma
Continued survival benefit seen for nivolumab plus ipilimumab and for nivolumab monotherapy versus ipilimumab monotherapy
Neoadjuvant Chemo Boosts Structure Preservation Rates in Nasal, Sinus Cancer
Improvement seen in overall structure preservation rate, orbit preservation rate, and skull base preservation rate
FDA Expands Use of Breast Cancer Drug Kisqali
Model Can Predict, Stratify Liver Cancer Risk in Noncirrhotic Chronic Hep B
New model exhibited satisfactory discrimination and calibration, with c-statistics of 0.844 and 0.813 in derivation, validation cohorts
Aromatase Inhibitors Not Linked to CAC in Postoperative Breast Cancer Patients
Independent risk factors for CAC include older age, lower hemoglobin levels, hypertension, diabetes
Early, Virtual Palliative Care Feasible for Advanced Lung Cancer
Study shows similar effects on quality of life as in-person visits
Lactated Ringer Solution Better Than Normal Saline for Sickle Cell Pain Crises
Findings seen for patients receiving ≥2 L on day 1 of inpatient stay
Study Looks at Sex Differences in Melanoma Incidence
Melanoma incidence highest on trunk in men; incidence historically highest on limbs in women, but recent increases seen in truncal melanoma
AI Can Use ECG Images to Define Risk for Cancer Therapy-Linked Cardiac Dysfunction
In recent study, incidence of CTRCD and LVEF <40 percent were higher in association with high- versus low-risk AI ECG screen
